Hrt Financial LP X4 Pharmaceuticals, Inc Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.61 - $0.99 $10,421 - $16,913	17,084 New	17,084 $14,000
Q4 2021 Feb 14, 2022	SELL	$1.9 - $5.6 $65,966 - $194,426	-34,719 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $71,442 - $101,722	-15,771 Reduced 31.24%	34,719 $183,000
Q2 2021 Aug 16, 2021	BUY	$6.49 - $9.56 $327,680 - $482,684	50,490 New	50,490 $328,000

103

99.9M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $41.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.